Biological
Cytokine-Induced Killer Cells clinical trials
- studies test it
- 19
- open now
- 2
- in phase 3
- 3
- first study started
- 2008
Keep track of what changes. Save the Cytokine-Induced Killer Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- CIK
- 10
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2015 (7)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 15
- Phase 3
- 3
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 19
The First People's Hospital of Changzhou (10) · Capital Medical University (1) · China Meitan General Hospital (1) · Sun Yat-sen University (1) · Washington University School of Medicine (1) · Henan Cancer Hospital (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Shenzhen Second People's Hospital (1)
Often tested with
Tested in the same studies.
Dendritic Cell (2) · FOLFOX-4 Regimen (1) · Fludarabine (1) · Cyclophosphamide (1) · Interleukin-2 (1) · Nogapendekin alfa inbakicept (1)
Studies
Open first, then newest update. How each study uses Cytokine-Induced Killer Cells is read from its arms, and is right about nine times in ten.
Testing it · 19
- Treatment of CIK for Patients With Refractory Non-Hodgkin LymphomaNot yet recruitingPhase 2The First People's Hospital of ChangzhouNCT02497898Written as Cytokine-induced killer cells (CIK)
- CIK in Treating Patients With Esophageal CancerNot yet recruitingPhase 2The First People's Hospital of ChangzhouNCT02490735Written as Cytokine-induced Killer Cells
- Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK ImmunotherapyCompletedNot applicableCapital Medical UniversityNCT01906632Written as DC-CIK Immunotherapy
- Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)TerminatedPhase 1/2Washington University School of MedicineNCT01898793Written as Cytokine-induced killer cells
- Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer CellsStatus unknownPhase 1/2Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusNCT05108077Written as cytokine-induced killer cells
- Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic CancerTerminatedPhase 2Henan Cancer HospitalNCT03002831Written as Cytokine-induced Killer Cells
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With CholangiocarcinomaActive, not recruitingPhase 2/3The First People's Hospital of ChangzhouNCT02482454Written as Cytokine-induced killer cells
- Safety and Efficacy of Immune Therapy for CondylomaStatus unknownNot applicableShenzhen Second People's HospitalNCT03158480Written as DC-CIK immunotherapy
- Chemotherapy Combined With CIK Treating Colon CancerCompletedPhase 4China Meitan General HospitalNCT03084809Written as Cytokine-induced killer cells+ FOLFOX4
- Study of DC-CTL Combined With CIK for Advanced Solid TumorStatus unknownPhase 1/2Xiaoyi HuangNCT03047525Written as Cytokine-induced Killer Cells
- CIK Treatment for HCC Patient Underwent Radical ResectionCompletedPhase 3Sun Yat-sen UniversityNCT01749865Written as Cytokine-Induced Killer Cells
- The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02487992Written as Cytokine-Induced Killer Cells
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02490748Written as Cytokine-induced killer cells
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian CarcinomaActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02487693Written as Cytokine-induced killer cells
- CIK in Treating Patients With Bladder CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02489890Written as Cytokine-induced Killer Cells
- The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02485015Written as Cytokine-Induced Killer Cells
- The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFRActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02493582Written as Cytokine-Induced Killer Cells
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver MetastasesCompletedPhase 2/3The First People's Hospital of ChangzhouNCT02419677Written as Cytokine-induced killer cells
- Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon CancerStatus unknownPhase 2Yanjuan ZhuNCT01929499Written as cytokine-induced killer cells
Given in every arm · 3 — Cytokine-Induced Killer Cells is usual care beside what is tested
- Cytokine-induced Killer Study for Patients With Stage II MelanomaNot yet recruitingPhase 2The First People's Hospital of ChangzhouNCT02498756Written as Cytokine-induced killer cells
- Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaTerminatedPhase 1/2Capital Medical UniversityNCT03393858Written as DC-CIK Immunotherapy
- Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast CancerActive, not recruitingPhase 2The First People's Hospital of ChangzhouNCT02491697Written as DC-CIK Immunotherapy